You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
片仔癀(600436.SH):藥品生產許可證變更
格隆匯 05-16 17:58

格隆匯5月16日丨片仔癀(600436.SH)公佈,近日,公司收到福建省藥品監督管理局核准簽發的《藥品生產許可證》,同意公司《藥品生產許可證》增加委託生產,受託生產企業是山東朗諾製藥有限公司,受託生產地址是山東省德州市齊河縣晏北街道辦事處齊眾大道127號,受託生產產品是地氯雷他定口服溶液(規格:30ml:15mg,批准文號:國藥準字H20213056)。

此次通過實施上市許可持有人制度,有利於公司整合和分配生產資源,提高產能利用率,降低生產成本,不斷完善公司對藥品的全生命週期質量管理。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account